Skip to main content


We’re sorry, something doesn't seem to be working properly. Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.

Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

  • Charissa Borja-Tabora1,
  • Cecilia Montalban2,
  • Ziad A Memish3Email author,
  • Marie Van der Wielen4,
  • Veronique Bianco4,
  • Dominique Boutriau4 and
  • Jacqueline Miller5
BMC Infectious Diseases201313:116

DOI: 10.1186/1471-2334-13-116

Received: 23 May 2012

Accepted: 26 February 2013

Published: 5 March 2013

Authors’ Affiliations

Research Institute for Tropical Medicine
Philippine General Hospital Manila
College of Medicine, Alfaisal University
GlaxoSmithKline Vaccines
GlaxoSmithKline Vaccines